Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
tirzepatide took 72 weeks to reach 20.9%
The provider assesses contraindications, medication interactions, and whether GLP-1 therapy is appropriate
Most private providers follow criteria broadly aligned with NICE guidance: A BMI of 30 or above , or A BMI of 37 or above alongside a weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea Some providers may consider patients with a BMI slightly below these thresholds at clinical discretion
More Ways to Benefit Related Benefit 1 Related Benefit 2 Related Benefit 3 Related Benefit 4 Related Benefit 5 And Wegovy, also approved for weight loss, can be prescribed to reduce the risk of a heart attack, stroke or other serious cardiovascular events in overweight adults with heart disease
